Koers Novogen Limited Australian S.E.
Aandelen
AU000000NRT0
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 10K 6,61K 6,16K | Omzet 2023 | 555 367,02 341,82 | Marktkapitalisatie | 39,72 mln. 26,26 mln. 24,46 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -24 mln. -15,87 mln. -14,78 mln. | Nettowinst (verlies) 2023 | -20 mln. -13,23 mln. -12,32 mln. | EV/omzet 2022 | 7.714 x |
Nettoliquiditeiten 2022 | 7,36 mln. 4,87 mln. 4,53 mln. | Nettoliquiditeiten 2023 | 3,44 mln. 2,28 mln. 2,12 mln. | EV/omzet 2023 | 65.355 x |
K/w-verhouding 2022 |
-3,27
x | K/w-verhouding 2023 |
-1,55
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,6% |
Recentste transcriptie over Novogen Limited
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,66% | 53,67 mld. | |
+33,67% | 38,86 mld. | |
-7,81% | 38,76 mld. | |
-10,77% | 27,27 mld. | |
+11,77% | 25,91 mld. | |
-17,82% | 20,29 mld. | |
+35,09% | 12,78 mld. | |
+29,17% | 12,18 mld. | |
-3,05% | 11,96 mld. |